![Gene Mack](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gene Mack
Directeur Général chez
GAIN THERAPEUTICS, INC.
Fortune : 28 080 $ au 31/05/2026
Profil
Gene C.
Mack is President, Chief Executive Officer & Director at Gain Therapeutics, Inc. starting in 2025.
Former positions include Executive Director at Mizuho Securities USA LLC (2011), Senior Director-Finance & Investor Relations at Edge Therapeutics, Inc. (2013–2015), Managing Director at Brean Capital LLC (2012–2014), Chief Financial Officer & Treasurer at SELLAS Life Sciences Group, Inc. (2018), Chief Financial Officer & Senior Vice President at Ascendia Pharmaceuticals, Inc. (2015–2017), Chief Financial Officer at ImCyse SA (2021–2023), Research Analyst at Soleil Securities Corp.
(2009–2011), Analyst at HSBC Securities (USA), Inc. (2007), Analyst at Ryan, Beck & Co., Inc. (2004), Research Analyst at FM Partners Holdings LLC (2008–2009), and Chief Financial Officer at OncoC4, Inc. Education includes undergraduate and MBAistration degrees from Fordham University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 27/04/2026 | 14 400 ( 0,03% ) | 28 080 $ | 31/05/2026 |
Postes actifs de Gene Mack
| Sociétés | Poste | Début |
|---|---|---|
| GAIN THERAPEUTICS, INC. | Directeur Général | 25/06/2024 |
Anciens postes connus de Gene Mack
| Sociétés | Poste | Fin |
|---|---|---|
ImCyse SA
 ImCyse SA BiotechnologyHealth Technology Engages in the development of curative therapies in the field of immune and allergic pathologies | Directeur Financier/CFO | 01/10/2023 |
| SELLAS LIFE SCIENCES GROUP, INC. | Directeur Financier/CFO | 17/12/2018 |
Ascendia Pharmaceuticals, Inc.
 Ascendia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical contract formulation development and manufacturing organization | Directeur Financier/CFO | 01/01/2017 |
Edge Therapeutics, Inc.
 Edge Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company which develops therapies | Investor Relations Contact | 01/01/2015 |
Brean Capital LLC
 Brean Capital LLC Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01/03/2014 |
Formation de Gene Mack
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
75
Relations au 1er degré
14
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 14 |
|---|---|
Ryan, Beck & Co., Inc.
 Ryan, Beck & Co., Inc. Investment Banks/BrokersFinance Provides brokerage and investment banking services | Finance |
Soleil Securities Corp.
 Soleil Securities Corp. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Mizuho Securities USA LLC
 Mizuho Securities USA LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
HSBC Securities (USA), Inc.
 HSBC Securities (USA), Inc. Regional BanksFinance Provides banking and financial services | Finance |
Edge Therapeutics, Inc.
Edge Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company which develops therapies | Health Technology |
FM Partners Holdings LLC
 FM Partners Holdings LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Gruntal & Co. LLC
 Gruntal & Co. LLC General GovernmentGovernment Provides financial services | Government |
Fordham University
 Fordham University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Brean Capital LLC
Brean Capital LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
ImCyse SA
ImCyse SA BiotechnologyHealth Technology Engages in the development of curative therapies in the field of immune and allergic pathologies | Health Technology |
SELLAS Life Sciences Group, Inc.
 SELLAS Life Sciences Group, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Health Technology |
Ascendia Pharmaceuticals, Inc.
Ascendia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical contract formulation development and manufacturing organization | Health Technology |
Gain Therapeutics, Inc.
 Gain Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company | Health Technology |
Oncoc4, Inc.
 Oncoc4, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel medicines for cancer | Health Technology |
